Aflac (AFL) to Release Earnings on Wednesday

Aflac (NYSE:AFL) is set to announce its earnings results after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of $1.59 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Aflac (NYSE:AFL) last released its earnings results on Monday, May 6th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.08. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The business had revenue of $5.44 billion for the quarter, compared to analysts’ expectations of $4.09 billion. During the same period last year, the company earned $1.55 earnings per share. The company’s quarterly revenue was up 13.3% on a year-over-year basis. On average, analysts expect Aflac to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Price Performance

AFL opened at $94.56 on Tuesday. The company’s 50 day simple moving average is $89.94 and its 200 day simple moving average is $85.31. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.08 and a current ratio of 0.08. Aflac has a 1 year low of $71.97 and a 1 year high of $95.49. The stock has a market capitalization of $53.73 billion, a PE ratio of 10.44, a P/E/G ratio of 2.59 and a beta of 0.95.

Aflac Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 3rd. Investors of record on Wednesday, May 22nd were given a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, May 21st. This is a boost from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 annualized dividend and a dividend yield of 2.12%. Aflac’s dividend payout ratio (DPR) is currently 22.08%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Truist Financial raised their target price on shares of Aflac from $80.00 to $82.00 and gave the stock a “hold” rating in a research report on Friday, May 3rd. Bank of America lifted their price target on shares of Aflac from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, July 11th. Citigroup lifted their price target on shares of Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. Morgan Stanley boosted their target price on shares of Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Finally, Jefferies Financial Group reduced their target price on shares of Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research report on Friday, June 28th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $86.46.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 600 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $84.84, for a total value of $50,904.00. Following the sale, the director now directly owns 27,550 shares of the company’s stock, valued at $2,337,342. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Aflac news, Director Joseph L. Moskowitz sold 600 shares of the stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $84.84, for a total transaction of $50,904.00. Following the sale, the director now directly owns 27,550 shares of the company’s stock, valued at $2,337,342. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Charles D. Lake II sold 22,378 shares of the stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the sale, the director now directly owns 61,522 shares in the company, valued at $5,381,329.34. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.